These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1179028)

  • 1. Effects of neonatal 6-hydroxydopa treatment on monamine content of rat brain and peripheral tissues.
    Kostrzewa RM
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):567-79. PubMed ID: 1179028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 6-hydroxydopa on noradrenergic neurons in developing rat brain.
    Kostrzewa RM; Garey RE
    J Pharmacol Exp Ther; 1976 Apr; 197(1):105-18. PubMed ID: 1263125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an opioid-specific action of morphine in modifying recovery of neonatally-damaged noradrenergic fibers in rat brain.
    Kostrzewa RM; Klisans-Fuenmayor D
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):3-11. PubMed ID: 6438742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate-enhanced toxicity and noradrenergic sprouting in rats treated with 6-hydroxydopa.
    Harston CT; Clark MB; Hardin JC; Kostrzewa RM
    Eur J Pharmacol; 1981 May; 71(4):365-73. PubMed ID: 6788574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental localization of noradrenergic innervation to the rat cerebellum following neonatal 6-hydroxydopa and morphine treatment.
    Harston CT; Clark MB; Hardin JC; Kostrzewa RM
    Dev Neurosci; 1982; 5(2-3):252-62. PubMed ID: 6813097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in noradrenergic innervation of the brain following dorsal bundle lesions in neonatal rats.
    Klisans-Fuenmayor D; Harston CT; Kostrzewa RM
    Brain Res Bull; 1986 Jan; 16(1):47-54. PubMed ID: 3082466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post mortem stability of catecholamines in discrete regions of rat brain.
    Roubein IF; Embree LJ
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):143-53. PubMed ID: 441508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats.
    Berkowitz BA; Arleth AJ; Sung CP; Kruse LI; DeWolf WE; Ohlstein EH
    J Pharmacol Exp Ther; 1988 Jun; 245(3):850-7. PubMed ID: 3385645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 6-hydroxydopamine and 6-hydroxydopa on development of behavior.
    Morgan DN; McLean JH; Kostrzewa RM
    Pharmacol Biochem Behav; 1979 Sep; 11(3):309-12. PubMed ID: 504311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of sprouting of noradrenergic terminals in rat and mouse cerebellum after neonatal 6-hydroxydopa.
    Kostrezewa RM; Klara JW; Robertson J; Walker LC
    Brain Res Bull; 1978; 3(5):525-31. PubMed ID: 122764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel stressors affected catecholamine stores in socially isolated normotensive and spontaneously hypertensive rats.
    Gavrilovic L; Spasojevic N; Dronjak S
    Auton Neurosci; 2005 Oct; 122(1-2):38-44. PubMed ID: 16172022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in regional brain catecholamines during and after acute hemorrhage in the rat.
    Yu TL; McIntosh TK
    Circ Shock; 1993 Nov; 41(3):138-43. PubMed ID: 8269642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.
    Richardson JS; Cowan N; Hartman R; Jacobowitz DM
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):29-44. PubMed ID: 4847904
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistent alteration of rat brain monoamine levels by carbon monoxide exposure: sex differences and behavioral correlation.
    Shellenberger MK
    Neurotoxicology; 1981 Nov; 2(3):431-41. PubMed ID: 7199683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of postnatal 6-hydroxydopamine treatment on tissue catecholamine levels.
    Lytle LD; Shoemaker WJ; Cottman K; Wurtman RJ
    J Pharmacol Exp Ther; 1972 Oct; 183(1):56-64. PubMed ID: 5080034
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
    de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
    Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A short-term diabetes induced changes of catecholamines and p38-MAPK in discrete areas of rat brain.
    Ramakrishnan R; Kempuraj D; Prabhakaran K; Jayakumar AR; Devi RS; Suthanthirarajan N; Namasivayam A
    Life Sci; 2005 Aug; 77(15):1825-35. PubMed ID: 16009379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketanserin reduces a particular monoamine pool in peripheral tissues.
    Leysen JE; Wynants J; Eens A; Janssen PA
    Mol Pharmacol; 1989 Mar; 35(3):375-80. PubMed ID: 2927387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats.
    Bhargava HN; Matwyshyn GA; Rattan AK; Koo KL; Tejwani GA
    J Pharmacol Exp Ther; 1994 Feb; 268(2):856-61. PubMed ID: 8113998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypersensitivity of cardiac beta-adrenergic receptors after neonatal treatment of rats with 6-hydroxydopa.
    Nomura Y; Kajiyama H; Segawa T
    Eur J Pharmacol; 1980 Aug; 66(2-3):225-32. PubMed ID: 6254784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.